This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| National Alzheimer's Coordinating Center | |
|---|---|
| Name | National Alzheimer's Coordinating Center |
| Formation | 1999 |
| Headquarters | Seattle, Washington |
| Parent organization | National Institute on Aging |
National Alzheimer's Coordinating Center is a research organization that aggregates clinical, neuropathologic, and biomarker data from Alzheimer's Disease Research Centers. It supports translational and epidemiologic studies by providing standardized datasets and analytic support to investigators at institutions such as University of Washington, Columbia University, Johns Hopkins University, Mayo Clinic, and Mount Sinai Health System. The center collaborates with federal agencies like the National Institutes of Health, academic consortia including the Alzheimer's Disease Neuroimaging Initiative, and international initiatives such as the European Alzheimer's Disease Consortium.
The center was established as part of an effort coordinated by the National Institute on Aging and linked programs including the Alzheimer's Disease Research Centers program and the Consortium to Establish a Registry for Alzheimer's Disease. Early leadership engaged investigators from University of Washington, University of California, San Diego, University of Pittsburgh School of Medicine, and Oregon Health & Science University. Over time the center interfaced with projects like the Cardiovascular Health Study, the Framingham Heart Study, and the Religious Orders Study and Memory and Aging Project to harmonize longitudinal clinical and neuropathologic data. Notable collaborations connected the center to diagnostic criteria revisions influenced by work at McGill University, Beth Israel Deaconess Medical Center, and Massachusetts General Hospital.
The center's mission aligns with priorities set by National Institute on Aging directors and advisory panels including the National Advisory Council on Aging. Objectives include creating standardized data dictionaries used by networks such as the Alzheimer's Disease Neuroimaging Initiative and supporting multicenter studies involving centers at Yale University, Harvard Medical School, Stanford University School of Medicine, Duke University School of Medicine, and University of California, Los Angeles. It aims to accelerate discovery in areas highlighted by summits at American Association for Geriatric Psychiatry, Society for Neuroscience, and Alzheimer's Association meetings. The center also supports harmonization efforts referenced by guidelines from World Health Organization advisory groups and panels from Institute of Medicine.
The center curates longitudinal clinical datasets, neuropathologic summaries, and biomarker panels aggregated from centers including Mayo Clinic, Washington University School of Medicine in St. Louis, University of Pennsylvania, University of Michigan Hospital, and University of California, San Francisco. Major data products are used alongside repositories like the Alzheimer's Disease Neuroimaging Initiative imaging archive, the Global Alzheimer's Association Interactive Network, and the NIAGADS genetics database. Data standards reference nomenclature systems developed at International Working Group on the Clinical Characterisation of Cognitive Decline and tools from National Library of Medicine. The center's databases have been integrated into analytic platforms used by researchers at Broad Institute, Sanger Institute, and Wellcome Trust Centre for Human Genetics.
The center supports research on neuropathology, cognitive trajectories, and biomarkers through collaborations with investigators at Columbia University Irving Medical Center, Baylor College of Medicine, Emory University School of Medicine, Vanderbilt University Medical Center, and University of Toronto. Multidisciplinary studies linked the center to neuroimaging groups at Massachusetts General Hospital Martinos Center, geneticists at University of Oxford, and clinical trial networks like Alzheimer's Disease Cooperative Study. It has contributed to meta-analyses appearing alongside work from International Genomics of Alzheimer's Project, European Alzheimer’s Disease Initiative, and cohorts such as Baltimore Longitudinal Study of Aging. Collaborative efforts extend to patient advocacy organizations including Alzheimer's Association, UsAgainstAlzheimer's, and international charities like Alzheimer Society of Canada.
Governance structures involve oversight from advisory boards including representatives from National Institute on Aging, academic leaders from University of California, Davis, University of Southern California, and participant centers such as University of Kentucky. Funding streams incorporate grants and cooperative agreements administered by National Institutes of Health components, partnerships with philanthropic organizations like Bill & Melinda Gates Foundation for data-sharing initiatives, and contributions from foundations including Robert Wood Johnson Foundation and Michael J. Fox Foundation for Parkinson's Research for cross-disease studies. Compliance and policy guidance reference standards set by Office for Human Research Protections and data-sharing expectations from the National Academies of Sciences, Engineering, and Medicine.
The center offers training materials, workshops, and webinars used by clinicians and researchers at institutions including Rush University Medical Center, Northwestern University Feinberg School of Medicine, University of Chicago, University of Illinois Chicago, and Case Western Reserve University. Outreach activities align with conferences hosted by Alzheimer's Association International Conference, Gerontological Society of America, and regional meetings of the Society for Behavioral Neuroendocrinology. Educational collaborations include curriculum development with programs at Johns Hopkins Bloomberg School of Public Health and mentoring schemes similar to initiatives at Howard University and Meharry Medical College to increase diversity in research.
Analyses using the center's datasets have influenced diagnostic frameworks refined at National Institute on Aging–Alzheimer's Association consensus meetings, supported neuropathologic staging schemes originally developed at Staging of Alzheimer-related changes (Braak and Braak) studies, and informed biomarker research linked to work at Alzheimer's Disease Neuroimaging Initiative. Key findings include characterization of clinical heterogeneity described in studies alongside investigators from Mayo Clinic, identification of mixed pathologies reported in cohorts like the Religious Orders Study, and genotype-phenotype associations corroborated by International Genomics of Alzheimer's Project. The center's resources have been cited in policy discussions involving Centers for Medicare & Medicaid Services and translational efforts connected to biotech partners such as Biogen, Eli Lilly and Company, and Roche.
Category:Alzheimer's disease research